FDA Recall Open, Classified

BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva specimens.

Recall: Z-2023-2024 · Initiated May 7, 2024

Recall

Recall Number
Z-2023-2024
Event Number
94599
Firm
Becton Dickinson & Co.
FEI Number
1119779
Product Code
QJR
Status
Open, Classified
Root Cause
Component design/selection
Initiated
May 7, 2024
Posted
June 5, 2024
Address
7 Loveton Cir, Sparks, MD, 21152-9212

Description

BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva specimens.

Reason

Assays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.

Action

Consignees were mailed and/or emailed an URGENT: Medical Device Product Correction notification, dated 5/7/24. The notification instructs consignees to immediately inspect their inventory for affected devices and destroy them per the consignee's destruction process, ensure the notification is read and understood, disseminate the notification to among those in your organization and customers who should be made aware, and return the completed Response Form to BD by email to [email protected] or by fax to 312-949-0438. Consignees with any complaints can call 1-844-823-5433 or email [email protected]; consignees with any recall related questions can email [email protected].

Distribution

Domestic: Nationwide Distribution; Foreign: AU, BR, BE, CA, CO, & JP.

Quantity

2,061 kits